Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04797780
Title Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Syros Pharmaceuticals
Indications

myelodysplastic syndrome

Therapies

Azacitidine

Azacitidine + Tamibarotene

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN | BEL | AUT


No variant requirements are available.